Copeland Capital Management’s LifeVantage LFVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,712
Closed -$20.4K 278
2026
Q1
$20.4K Buy
4,712
+174
+4% +$911 ﹤0.01% 235
2025
Q4
$28K Hold
4,538
﹤0.01% 231
2025
Q3
$44.2K Sell
4,538
-44
-1% -$551 ﹤0.01% 217
2025
Q2
$59.9K Buy
4,582
+645
+16% +$8.34K ﹤0.01% 191
2025
Q1
$57.4K Buy
3,937
+205
+5% +$3.87K ﹤0.01% 172
2024
Q4
$65.4K Buy
+3,732
New +$52.3K ﹤0.01% 169

Other funds holding LFVN

Copeland Capital Management's LFVN Position: Q2 2026 in Review

Copeland Capital Management sold out of LifeVantage (LFVN) in Q2 2026, closing a stake of 4,712 shares — an estimated $20.4K sold.

Copeland Capital Management first reported a position in LFVN in Q4 2024 and held it in 6 quarters. The position peaked at $65.4K in Q4 2024. 89 funds tracked by Wall St. Rank hold LFVN as of Q2 2026.

  • Copeland Capital Management reported no remaining LifeVantage position as of Q2 2026 after selling out during the quarter.
  • Copeland Capital Management sold 4,712 LifeVantage shares in Q2 2026, an estimated $20.4K.
  • Copeland Capital Management first reported a position in LifeVantage in Q4 2024 and held it in 6 quarters.
  • Copeland Capital Management's LifeVantage position peaked at $65.4K in Q4 2024.
  • 89 funds tracked by Wall St. Rank held LifeVantage as of Q2 2026.

Based on Copeland Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.